Groundbreaking AI research aims to develop all-in-one health super drug - Institute for Respiratory Health

Groundbreaking AI research aims to develop all-in-one health super drug

Sunday, February 25, 2024 | News

As the population around the world ages, health professionals face the challenge of treating patients with multiple health issues including, diabetes, heart issues and emphysema.

Researchers at the Institute for Respiratory Health are taking a whole new approach to this problem. Rather than tackling each health issue in isolation, their focus is on developing a super pill that could address multiple health problems simultaneously.

Professor Yuben Moodley from the Institute who is leading the research project said, “Our vision to create a pill that serves as a one-stop solution for older people facing multiple health concerns.

“This could bring many potential benefits for older people; it would offer a more cost-effective and convenient alternative while potentially minimising the side effects from taking several medications daily.

“Artificial Intelligence (AI) will play a big part in our research, acting like a super-smart assistant to help us get results sooner.”

If the research project is successful, it could be a game changer for those facing multiple health issues and reduce the number of prescriptions needed to maintain wellbeing.  

“We want to make life easier for older people,” Professor Moodley said.

“Taking different medications daily can be confusing and some people may forget or skip doses.”

The innovative research project received a $50,000 Innovative Challenge 2023 – Generative Artificial Intelligence grant, part of the Western Australia (WA) Future Health Research and Innovation Fund.

September AI Labs, a leading artificial intelligence consultancy in Perth, are working with the Insitute for Respiratory Health in relation to this groundbreaking initiative.